Abstract:CRISPR-Cas are adaptable natural prokaryotic defense systems that act against invading viruses and plasmids. Among the six currently known major CRISPR-Cas types, the type VI CRISPR-Cas13 is the only one known to exclusively bind and cleave foreign RNA. Within the last couple of years, this system has been adapted to serve numerous, and sometimes not obvious, applications, including some that might be developed as effective molecular therapies. Indeed, Cas13 has been adapted to kill antibiotic-resistant bacteria. In a cell-free environment, Cas13 has been used in the development of highly specific, sensitive, multiplexing-capable, and field-adaptable detection tools. Importantly, Cas13 can be reprogrammed and applied to eukaryotes to either combat pathogenic RNA viruses or in the regulation of gene expression, facilitating the knockdown of mRNA, circular RNA, and noncoding RNA. Furthermore, Cas13 has been harnessed for in vivo RNA modifications including programmable regulation of alternative splicing, A-to-I and C to U editing, and m6A modifications. Finally, approaches allowing for the detection and characterization of RNA-interacting proteins have also been demonstrated. Here, we provide a comprehensive overview of the applications utilizing CRISPR-Cas13 that illustrate its versatility. We also discuss the most important limitations of the CRISPR-Cas13-based technologies, and controversies regarding them.This article is categorized under: RNA Methods > RNA Analyses in CellsRNA Processing > RNA Editing and ModificationRNA Interactions with Proteins and Other Molecules > Protein-RNA Interactions: Functional Implications

Intrinsic targeting of host RNA by Cas13 constrains its utility

Intrinsic RNA Targeting Constrains the Utility of CRISPR-Cas13 Systems

Intrinsic RNA-targeting activity limits the applicability of CRISPR-Cas13

Inactivation of Latent HIV-1 Proviral DNA Using Clustered Regularly Interspaced Short Palindromic Repeats/Cas9 Treatment and the Assessment of Off-Target Effects.

Insights Gained from RNA Editing Targeted by the CRISPR-Cas13 Family

Intrinsic RNA Targeting Triggers Indiscriminate DNase Activity of CRISPR‐Cas12a

Applications of the versatile CRISPR‐Cas13 RNA targeting system

Molecular mechanism for target RNA recognition and cleavage of Cas13h

High-fidelity Cas13 variants for targeted RNA degradation with minimal collateral effects.

Low copy CRISPR-Cas13d mitigates collateral RNA cleavage

Genome Scale Screening Identification of SaCas9/gRNAs for Targeting HIV-1 Provirus and Suppression of HIV-1 Infection

Programmable RNA targeting with CRISPR-Cas13

Advances in CRISPR-Cas systems for RNA targeting, tracking and editing

The Effects of Length and Sequence of Grna on Cas13b and Cas13d Activity in Vitro and in Vivo

Engineered CRISPR RNA improves the RNA cleavage efficiency of hfCas13X

Targeting cellular mRNAs translation by CRISPR-Cas9

Advances in CRISPR-Cas Systems for RNA Targeting, Tracking and Editing.

Evaluation of the effect of RNA secondary structure on Cas13d-mediated target RNA cleavage

Massively parallel profiling of RNA-targeting CRISPR-Cas13d

Cytosolic CRISPR RNA for RNA-targeting CRISPR-Cas systems

Precise Interference of RNA-Protein Interaction by CRISPR-Cas13-Mediated Peptide Competition